ARL Bio Pharma provides analytical and microbiological testing for Canadian compounding pharmacies.
Submit samples for testing through ARL's Client Portal.
Services Offered:
This test measures the concentration of the active ingredient at a specific point in time.
Articles:
- Benefits of Submitting Master Formulation Records
- Chemical Testing Aspects of USP 797 for Compounded Sterile Preparations
- Drug Formulation and Its Impact on Analytical Testing
- Importance of Sample Amounts and the Impact on Potency Testing
- Potency Test Failure Case Studies
- Potency Test Results
- Potency Testing Benefits and Requirements
- Stability vs. Potency Testing
- T3/T4 Formulations
- Test Specifications
A stability study measures the extent to which a product retains, within specified limits, and throughout its period of storage and use, the same properties and characteristics that it possessed at the time of compounding.
A study commonly includes: a stability indicating method assay, sterility (for sterile preparations), endotoxin (for most sterile preparations), pH, visual inspection, particulate matter, preservative effectiveness, preservative quantification, microbial limits (for non-sterile preparations), and the absence of specified organisms (for non-sterile preparations).
Articles:
- Chemical Stability of Admixtures Containing Ziconotide 25 mcg-mL and Morphine Sulfate 10 mg-mL or 20 mg-mL During Simulated Intrathecal Administration
- Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
- Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
- Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin Metronidazole or Vancomycin During Simulated Y-Site Administration
- Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
- Compatibility of Micafungin Injection with Other Drugs During Simulated YSite Coadministration
- Drug Compatibility with a New Generation of VISIV Polyolefin Infustion Solution Containers
- Extending Beyond Use Date for Compounded Preparations
- Importance of Forced Degradation in Stability Indicating Methods
- Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
- Pharmaceutical Compounding Errors
- Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
- Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
- Proactive Approaches to Mitigate Stability Failures
- Quality Control Analytical Methods-Stability Versus Potency Testing-The Madness is in the Method
- Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
- Stability vs. Potency Testing
- What Factors Influence Stability?
Webinars:
- Beyond Use Date Strategies for Compounded Preparations
- Compounded Sterile Products: Extending Beyond Use Dating and Batch Release Testing for 503A and 503B Facilities
- Extending Beyond Use Dating for Compounded Preparations
- Root Causes of Stability Failures
- Stability Indicating Methods
- Stability Studies: Architecture Behind Establishing a Beyond Use Date
- Stability Testing: Science and Compliance
A sterility test detects microbial contamination. A satisfactory result indicates that no contaminating microorganism has been found in the sample examined under the conditions of the test.
Articles:
- Applications and Sterility of Autologous Serum Eye Drops
- Basics of Sterility Testing
- Laboratory Considerations of USP Chapter 71 Sterile Tests
- Method Suitability and Its Importance to the Test Method
- Open vs Closed Membrane Filtration Systems
- Sterility Test Failure: Possible Causes and Investigation
- The Importance of Sterility Test Volume and Method Suitability Testing
- USP 71 Sterility Testing
Webinars:
A rapid sterility test detects microbial contamination. This validated alternative sterility test method per USP <1223> is effective and reliable for 503A and 503B Facilities. Rapid test provides objective results in as little as six days.
Articles:
- Dispense Drugs Faster with Rapid Sterility
- Rapid Sterility Testing
- Rapid Sterility Testing for Compounding Pharmacies
Webinars:
An endotoxin test detects toxins that are released from the cell wall of disrupted gram-negative bacteria.
Articles:
- Comparison of Endotoxin Testing Methods for Pharmaceutical Products
- Endotoxin Testing with a Contract Testing Laboratory
- Endotoxin Challenge Vials
- Endotoxin Essentials
- Endotoxin Limits
- The Importance of Endotoxin Testing
- USP <85> Bacterial Endotoxin Validation and Its Importance to the Test Method
Webinars:
This test identifies microorganisms isolated during different phases of manufacturing and quality testing to the genus/species level using DNA sequencing.
Articles:
An antimicrobial effectiveness test demonstrates the effectiveness of antimicrobial preservatives in preventing microbial proliferation in injections, topicals, oral products, single dose vials, and antacids packaged in multiple-dose containers.
Articles:
- Essentials of United States Pharmacopeia Chapter 51 Antimicrobial Effectiveness Testing
- Minor Chapters, Major Impacts – What USP Chapters 51, 61, 62, and 1207 Mean for Your Compounding Practice
- USP <51> Antimicrobial Effectiveness Testing
Webinars:
These tests quantitate the total population of aerobic bacteria, yeast, and molds in raw materials, in-process samples, and finished products.
Articles:
- Microbial Tests for Non-Sterile Products
- Microbial Limit Tests for Nonsterile Pharmaceuticals Part 1
- Microbial Limit Tests for Nonsterile Pharmaceuticals-Part 2
- Minor Chapters, Major Impacts – What USP Chapters 51, 61, 62, and 1207 Mean for Your Compounding Practice
- USP <61> and USP <62> Microbial Tests for Non-Sterile Products
Webinars
- Microbiology Testing: USP Requirements for Sterile and Non-Sterile Preparations
- Minor Chapters, Major Impacts: What USP <51>, <61>, <62>, and <1207> mean for your Practice
These tests verify the absence of objectionable microorganisms in drug products and raw materials.
Articles:
- Microbial Tests for Non-Sterile Products
- Microbial Limit Tests for Nonsterile Pharmaceuticals Part 1
- Microbial Limit Tests for Nonsterile Pharmaceuticals-Part 2
- Minor Chapters, Major Impacts – What USP Chapters 51, 61, 62, and 1207 Mean for Your Compounding Practice
- USP <61> and USP <62> Microbial Tests for Non-Sterile Products
Webinars
- Microbiology Testing: USP Requirements for Sterile and Non-Sterile Preparations
- Minor Chapters, Major Impacts: What USP <51>, <61>, <62>, and <1207> mean for your Practice
A particulate matter tests for the presence of extraneous substances including: dust, glass, drug precipitates, rubber and other insoluble materials.
Articles:
Microbial cleaning studies are essential to validating a facility’s cleaning SOP. Pharmacies must demonstrate that cleaning agents, combined with instructions and procedures for their use, remove microbial contamination from surface areas where sterile drug products are compounded.
Articles:
This test measures the level of hazardous drug surface residue to verify workplace safety.
Available Drugs:
- 5-Fluorouracil
- Estriol
- Estradiol
- Estrone
- Finasteride
- Medroxyprogesterone Acetate
- Methotrexate
- Mitomycin
- Misoprostol
- Progesterone
- Testosterone
- Testosterone Cypionate
- Testosterone Enanthate
- Testosterone Propionate
- Voriconazole
If you would like to test for a drug not listed, please email info@arlok.com and request that a new drug be added to our testing library.
Articles:
- USP <800> Environmental Quality and Control
- USP <800> Surface Wipe Sampling
- USP <800> Why should you test?
- USP <800> Environmental Monitoring Requirements Q&A